New Tool Seen to Distinguish Malignant Pleural Mesothelioma from Benign Disease
Researchers have developed a new tool to diagnose malignant pleural mesothelioma (MPM) that combines differences seen in gene expression — which may also serve as disease biomarkers — with a...
View ArticleResearchers Develop More Feasible Method for Distinguishing MPM from Benign RMH
Immunohistochemistry, an imaging technique to detect the loss of two proteins, MTAP and BAP1, may help doctors distinguish between malignant pleural mesothelioma (MPM) and reactive mesothelial...
View ArticleResearchers Develop More Feasible Method for Distinguishing MPM from Benign RMH
Immunohistochemistry, an imaging technique to detect the loss of two proteins, MTAP and BAP1, may help doctors distinguish between malignant pleural mesothelioma (MPM) and reactive mesothelial...
View Article
More Pages to Explore .....